109 related articles for article (PubMed ID: 34449322)
1. Purified recombinant human Chromogranin A N46 peptide with remarkable anticancer effect on human colon cancer cells.
Okasha H; Samir S; Nasr SM
Bioorg Chem; 2021 Oct; 115():105266. PubMed ID: 34449322
[TBL] [Abstract][Full Text] [Related]
2. Molecular Design, Structural Analysis and Antifungal Activity of Derivatives of Peptide CGA-N46.
Li RF; Lu ZF; Sun YN; Chen SH; Yi YJ; Zhang HR; Yang SY; Yu GH; Huang L; Li CN
Interdiscip Sci; 2016 Sep; 8(3):319-26. PubMed ID: 27165480
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative effect and characterization of a novel antifungal peptide derived from human Chromogranin A.
Li RF; Lu YL; Lu YB; Zhang HR; Huang L; Yin Y; Zhang L; Liu S; Lu Z; Sun Y
Exp Ther Med; 2015 Dec; 10(6):2289-2294. PubMed ID: 26668630
[TBL] [Abstract][Full Text] [Related]
4. Recombinant Expression of Cec-B Peptide in Escherichia coli with a Significant Anticancer Effect on Hepatocellular Carcinoma.
Okasha H; Nasr SM; Samir S
Curr Pharm Biotechnol; 2021; 22(9):1235-1245. PubMed ID: 33397234
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human chromogranin A: expression, purification and characterization of the N-terminal derived peptides.
Taupenot L; Remacle JE; Helle KB; Aunis D; Bader MF
Regul Pept; 1995 Mar; 56(1):71-88. PubMed ID: 7770635
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of a novel antifungal peptide derived from human chromogranin a on the immunity of mice infected with Candida krusei.
Li R; Zhang L; Zhang H; Yi Y; Wang L; Chen L; Zhang L
Exp Ther Med; 2017 May; 13(5):2429-2434. PubMed ID: 28565859
[TBL] [Abstract][Full Text] [Related]
7. Anti-candidal activity of a novel peptide derived from human chromogranin A and its mechanism of action against
Li RF; Yan XH; Lu YB; Lu YL; Zhang HR; Chen SH; Liu S; Lu ZF
Exp Ther Med; 2015 Nov; 10(5):1768-1776. PubMed ID: 26640548
[No Abstract] [Full Text] [Related]
8. Lab-scale Preparation of Recombinant Human Insulin-like Growth Factor-1 in
Mohamed OA; Samir S; Omar H; Hassan EA; Abdelazeem E
Recent Pat Biotechnol; 2022 Aug; 16(3):266-280. PubMed ID: 35418294
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Characterization of a New Benzoindole Derivative with Apoptotic Activity Against Colon Cancer Cells.
Hajiaghaalipour F; Faraj FL; Bagheri E; Ali HM; Abdulla MA; Majid NA
Curr Pharm Des; 2017; 23(41):6358-6365. PubMed ID: 28325143
[TBL] [Abstract][Full Text] [Related]
10. Scalable Production of Recombinant Membrane Active Peptides and Its Potential as a Complementary Adjunct to Conventional Chemotherapeutics.
Rothan HA; Ambikabothy J; Abdulrahman AY; Bahrani H; Golpich M; Amini E; A Rahman N; Teoh TC; Mohamed Z; Yusof R
PLoS One; 2015; 10(9):e0139248. PubMed ID: 26418816
[TBL] [Abstract][Full Text] [Related]
11. Optimization of the Expression Conditions of CGA-N46 in Bacillus subtilis DB1342(p-3N46) by Response Surface Methodology.
Li RF; Wang B; Liu S; Chen SH; Yu GH; Yang SY; Huang L; Yin YL; Lu ZF
Interdiscip Sci; 2016 Sep; 8(3):277-83. PubMed ID: 26341498
[TBL] [Abstract][Full Text] [Related]
12. Optimization of the expression conditions of CGA-N46 in Bacillus subtilis DB1342(p-3N46) by response surface methodology.
Li RF; Wang B; Liu S; Chen SH; Yu GH; Yang SY; Huang L; Yin YL; Lu ZF
Interdiscip Sci; 2015 Feb; ():. PubMed ID: 25682381
[TBL] [Abstract][Full Text] [Related]
13. Construction of an Anticancer Fusion Peptide (ACFP) Derived from Milk Proteins and an Assay of Anti-ovarian Cancer Cells in vitro.
Zhou J; Yang X; Zhang W; Wang J; Wei C; Gu F; Lei T; Qin Y
Anticancer Agents Med Chem; 2017; 17(4):635-643. PubMed ID: 27357543
[TBL] [Abstract][Full Text] [Related]
14. Anti-Tumor Mechanisms of Novel 3-(4-Substituted Benzyl)-5-Isopropil-5- Phenylhydantoin Derivatives in Human Colon Cancer Cell Line.
Obradović A; Matić M; Ognjanović B; Vuković N; Vukić M; Đurđević P; Ušćumlić G; Božić B; Nedeljković BB
Anticancer Agents Med Chem; 2019; 19(12):1491-1502. PubMed ID: 31840594
[TBL] [Abstract][Full Text] [Related]
15. Induction of HT-29 Colon Cancer Cells Apoptosis by Pyrogallol with Growth Inhibiting Efficacy Against Drug-Resistant
Revathi S; Hakkim FL; Kumar NR; Bakshi HA; Rashan L; Al-Buloshi M; Hasson SSAA; Krishnan M; Javid F; Nagarajan K
Anticancer Agents Med Chem; 2018; 18(13):1875-1884. PubMed ID: 30081791
[TBL] [Abstract][Full Text] [Related]
16. Proteolytic cleavage of human chromogranin a containing naturally occurring catestatin variants: differential processing at catestatin region by plasmin.
Biswas N; Vaingankar SM; Mahata M; Das M; Gayen JR; Taupenot L; Torpey JW; O'Connor DT; Mahata SK
Endocrinology; 2008 Feb; 149(2):749-57. PubMed ID: 17991725
[TBL] [Abstract][Full Text] [Related]
17. Biological Activity, Apoptotic Induction and Cell Cycle Arrest of New Hydrazonoyl Halides Derivatives.
Mohamed MF; Hassaneen HM; Elzayat EM; El-Hallouty SM; El-Manawaty M; Saleh FM; Mohamed Y; El-Zohiry D; Fahmy G; Abdelaal N; Hassanin N; Hossam N
Anticancer Agents Med Chem; 2019; 19(9):1141-1149. PubMed ID: 30843494
[TBL] [Abstract][Full Text] [Related]
18. Expression of Mastoparan B, a Venom Peptide, Via Escherichia coli C43 (DE3) Coupled with an Artificial Oil Body-Cyanogen Bromide Technology Platform.
Hsieh SK; Yu YJ; Tang NY; Lin JR; Jinn TR
Protein Pept Lett; 2017; 24(11):1021-1029. PubMed ID: 28741464
[TBL] [Abstract][Full Text] [Related]
19. Virtual Screening for Biomimetic Anti-Cancer Peptides from
Chantawannakul J; Chatpattanasiri P; Wattayagorn V; Kongsema M; Noikaew T; Chumnanpuen P
Molecules; 2021 Sep; 26(19):. PubMed ID: 34641308
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and evaluation of PD-L1 peptide antagonists as new anticancer agents for immunotherapy.
Orafaie A; Sadeghian H; Bahrami AR; Rafatpanah H; Matin MM
Bioorg Med Chem; 2021 Jan; 30():115951. PubMed ID: 33360579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
